The novel approach of tirzepatide peptide represents a major advance in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide774360.develop-blog.com/49945757/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment